Physician profile
Christopher Henry
NPI 1215295373
$4,196.87
in general payments reported to CMS, 2019-2025
22 companies · $1,087 in 2025
The $1,087 reported for 2025 was more than what a typical Pulmonary Disease provider received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,944 · 2020: $822 · 2021: $113 · 2022: $109 · 2023: $84.68 · 2024: $38.33 · 2025: $1,087.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $921 · Food and Beverage: $289.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $921.01 |
| Food and Beverage | $289.05 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| W. L. Gore & Associates, INC. | $2,403.89 | 2019-2020 | |
| Intuitive Surgical, INC. | $1,026.86 | 2025 | |
| Medtronic Vascular, INC. | $140.42 | 2020 | |
| Insmed, INC. | $99.60 | 2021-2022 | |
| Inogen, INC. | $71.39 | 2022-2024 | Inogen One G5 Oxygen Concentrator - Bluetooth |
| Boehringer Ingelheim Pharmaceuticals, INC. | $65.15 | 2019-2020 | |
| Glaxosmithkline, LLC. | $48.57 | 2019-2025 | Nucala |
| Jazz Pharmaceuticals INC. | $40.68 | 2019 | |
| Amgen INC. | $38.44 | 2022-2025 | Tezspire |
| Harmony Biosciences LLC | $38.12 | 2022-2023 | Wakix |
| Abbvie INC. | $32.20 | 2023 | |
| Allergan, INC. | $24.84 | 2019 | |
| Genentech, INC. | $21.80 | 2019 | |
| Mylan Specialty L.P. | $21.20 | 2022 | |
| Galvanize Therapeutics, INC | $20.70 | 2025 | Aliya System |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $17.50 | 2020 | |
| Inari Medical, INC. | $16.04 | 2023 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Tactile Systems Technology INC | $15.84 | 2021 | |
| Merck Sharp & Dohme LLC | $15.35 | 2021 | |
| Gilead Sciences, INC. | $13.64 | 2021 | |
| Tetraphase Pharmaceuticals, INC. | $12.74 | 2019 | |
| Getinge USA Sales, LLC | $11.90 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher Henry listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.